HEALTH CATALYST INC
HCATNASDAQTrading Snapshot
- Day Range
- $1.73 – $1.78
- 52-Week Range
- $0.96 – $3.62
- Volume
- $1.82B
- Avg Volume
- $1.32B
- Shares Outstanding
- 73.9M
- Next Earnings
- Dec 1, 2026
Fundamentals Snapshot
- Annual Revenue
- $311M
- Last Q Revenue
- $70M
- P/E Ratio
- —
- P/S Ratio
- 0.4x
- EPS (TTM)
- $-3.68
- Dividend Yield
- —
- Dilution (1yr)
- +13.8%
Why Investors Own HCAT
- ✓High-growth profile — revenue up +14.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 53% gross margin and 22% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
HEALTH CATALYST INC
HCAT
StockOtter · stockotter.spaceAbout HEALTH CATALYST INC
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SALT LAKE CITY, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health syst
Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
Reller Joins Health Catalyst as it Enters Its Next Phase of Growth SALT LAKE CITY, Sept. 14, 2026 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst", NASDAQ: HCAT), a healthcare intelligence company designed to acc
Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
SALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health syst
Hsbc Holdings PLC Invests $809,000 in Health Catalyst, Inc. $HCAT
Hsbc Holdings PLC bought a new stake in Health Catalyst, Inc. (NASDAQ: HCAT) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announc
Critical Survey: Aclarion (NASDAQ:ACONW) and Health Catalyst (NASDAQ:HCAT)
Health Catalyst (NASDAQ: HCAT - Get Free Report) and Aclarion (NASDAQ: ACONW - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strengt